<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mizutani A</submitter><funding>Shin Nippon Biomedical Laboratories, Ltd.</funding><funding>Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science</funding><pagination>1026</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9145277</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(5)</volume><pubmed_abstract>Single-photon emission computed tomography (SPECT) imaging using intravenous radioactive ligand administration to indirectly evaluate the time-dependent effect of intranasal drugs with poor blood-brain barrier permeability on brain drug distributions in mice was evaluated. The biodistribution was examined using domperidone, a dopamine D2 receptor ligand, as the model drug, with intranasal administration at 0, 15, or 30 min before intravenous [&lt;sup>123&lt;/sup>I]IBZM administration. In the striatum, [&lt;sup>123&lt;/sup>I]IBZM accumulation was significantly lower after intranasal (IN) domperidone administration than in controls 15 min after intravenous [&lt;sup>125&lt;/sup>I]IBZM administration. [&lt;sup>123&lt;/sup>I]IBZM SPECT was acquired with intravenous (IV) or IN domperidone administration 15 min before [</pubmed_abstract><journal>Pharmaceutics</journal><pubmed_title>Indirect SPECT Imaging Evaluation for Possible Nose-to-Brain Drug Delivery Using a Compound with Poor Blood-Brain Barrier Permeability in Mice.</pubmed_title><pmcid>PMC9145277</pmcid><funding_grant_id>01</funding_grant_id><funding_grant_id>18K19508 and 21H02865</funding_grant_id><pubmed_authors>Nishii R</pubmed_authors><pubmed_authors>Kawai K</pubmed_authors><pubmed_authors>Sasaki K</pubmed_authors><pubmed_authors>Torikai Y</pubmed_authors><pubmed_authors>Fukakusa S</pubmed_authors><pubmed_authors>Suzuki C</pubmed_authors><pubmed_authors>Magata Y</pubmed_authors><pubmed_authors>Muranaka Y</pubmed_authors><pubmed_authors>Ohuchi M</pubmed_authors><pubmed_authors>Kobayashi M</pubmed_authors><pubmed_authors>Haruta S</pubmed_authors><pubmed_authors>Mizutani A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Indirect SPECT Imaging Evaluation for Possible Nose-to-Brain Drug Delivery Using a Compound with Poor Blood-Brain Barrier Permeability in Mice.</name><description>Single-photon emission computed tomography (SPECT) imaging using intravenous radioactive ligand administration to indirectly evaluate the time-dependent effect of intranasal drugs with poor blood-brain barrier permeability on brain drug distributions in mice was evaluated. The biodistribution was examined using domperidone, a dopamine D2 receptor ligand, as the model drug, with intranasal administration at 0, 15, or 30 min before intravenous [&lt;sup>123&lt;/sup>I]IBZM administration. In the striatum, [&lt;sup>123&lt;/sup>I]IBZM accumulation was significantly lower after intranasal (IN) domperidone administration than in controls 15 min after intravenous [&lt;sup>125&lt;/sup>I]IBZM administration. [&lt;sup>123&lt;/sup>I]IBZM SPECT was acquired with intravenous (IV) or IN domperidone administration 15 min before [</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-22T18:21:51.093Z</modification><creation>2025-04-06T02:22:58.043Z</creation></dates><accession>S-EPMC9145277</accession><cross_references><pubmed>35631611</pubmed><doi>10.3390/pharmaceutics14051026</doi></cross_references></HashMap>